{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T12:18:52Z","timestamp":1703852332787},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.clinthera.2013.02.001","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T10:20:25Z","timestamp":1361874025000},"page":"286-293","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Combined Prednisone + Fluvastatin on Cholesterol and Bilirubin in Pediatric Patients With Minimal Change Nephropathy"],"prefix":"10.1016","volume":"35","clinical-trial-number":[{"clinical-trial-number":"chictr-tqr-12002602","registry":"10.18810\/chictr"}],"author":[{"given":"Minghui","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.02.001_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00008480-199904000-00010","article-title":"The idiopathic nephrotic syndrome","volume":"11","author":"Chesney","year":"1999","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.clinthera.2013.02.001_bib2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","volume":"105","author":"Hogg","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2013.02.001_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1440-1754.2007.01077.x","article-title":"Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study","volume":"43","author":"Wong","year":"2007","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.clinthera.2013.02.001_bib4","series-title":"Oxford Textbook of Clinical Nephrology","first-page":"461","article-title":"The nephrotic syndrome: management, complications and pathophysiology","author":"Cameron","year":"1998"},{"key":"10.1016\/j.clinthera.2013.02.001_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001533.pub4","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hodson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2013.02.001_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001537.pub4","article-title":"Interventions for minimal change disease in adults with nephrotic syndrome","author":"Palmer","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2013.02.001_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2013.02.001_bib8","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07104.x","article-title":"Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease","volume":"71","author":"Attman","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clinthera.2013.02.001_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00008480-200204000-00009","article-title":"Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management","volume":"14","author":"Saland","year":"2002","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.clinthera.2013.02.001_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0026-0495(90)90074-M","article-title":"Low-density lipoprotein metabolism in the nephrotic syndrome","volume":"39","author":"Warwick","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.clinthera.2013.02.001_bib11","doi-asserted-by":"crossref","first-page":"F823","DOI":"10.1152\/ajprenal.2001.280.5.F823","article-title":"Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome","volume":"280","author":"Vaziri","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clinthera.2013.02.001_bib12","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1523-1755.1998.00831.x","article-title":"Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis","volume":"53","author":"de Sain-van der Velden","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2013.02.001_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM199008303230905","article-title":"Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome","volume":"323","author":"Joven","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.02.001_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1523-1755.2001.00478.x","article-title":"Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome","volume":"59","author":"Shearer","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2013.02.001_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.1991.190","article-title":"Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria","volume":"40","author":"Warwick","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2013.02.001_bib16","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1681\/ASN.V351156","article-title":"Increased lipoprotein(a) concentrations in chronic renal failure","volume":"3","author":"Haffner","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2013.02.001_bib17","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2013.02.001_bib18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA reductase inhibitors","volume":"33","author":"Endo","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinthera.2013.02.001_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.02.001_bib20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart disease associated with nephrotic syndrome","volume":"44","author":"Ordonez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2013.02.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-74-1-1","article-title":"Serum cholesterol, lipoproteins, and the risk of coronary heart disease","volume":"74","author":"Kannel","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2013.02.001_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00862065","article-title":"Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood","volume":"10","author":"Coleman","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2013.02.001_bib23","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1345\/aph.1D587","article-title":"The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome","volume":"38","author":"Prescott","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2013.02.001_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-3476(97)70213-0","article-title":"Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy","volume":"130","author":"Sanjad","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2013.02.001_bib25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2013.02.001_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1357-2725(01)00130-3","article-title":"Bilirubin: its role in cytoprotection against oxidative stress","volume":"34","author":"Tomaro","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clinthera.2013.02.001_bib27","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","article-title":"Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation","volume":"269","author":"Neuzil","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinthera.2013.02.001_bib28","doi-asserted-by":"crossref","first-page":"P477","DOI":"10.1016\/0024-3205(94)90140-6","article-title":"Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox","volume":"54","author":"Wu","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.clinthera.2013.02.001_bib29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-2952(95)02395-X","article-title":"Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins","volume":"51","author":"Wu","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinthera.2013.02.001_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.89.3.495","article-title":"National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents","volume":"89","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2013.02.001_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5414\/CNP63074","article-title":"No effect of fluvastatin on the bone mineral density of children with minimal change glomerulonephritis and some focal mesangial cell proliferation, other than an ameliorating effect on their proteinuria","volume":"63","author":"Kano","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2013.02.001_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0272-6386(12)80587-7","article-title":"Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome","volume":"15","author":"Harris","year":"1990","journal-title":"Am J Kindey Dis"},{"key":"10.1016\/j.clinthera.2013.02.001_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ndt\/18.2.265","article-title":"HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats","volume":"18","author":"Usui","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2013.02.001_bib34","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1073\/pnas.122228799","article-title":"3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase\/p21 signaling pathway: implications for diabetic nephropathy","volume":"99","author":"Danesh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2013.02.001_bib35","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1159\/000079176","article-title":"Fluvastatin reduces renal fibroblast proliferation and production of type III collagen: therapeutic implications for tubulointerstitial fibrosis","volume":"97","author":"Ikeuchi","year":"2004","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.clinthera.2013.02.001_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00431-005-1720-1","article-title":"Increased oxidative stress in infants exposed to passive smoking","volume":"164","author":"Aycicek","year":"2005","journal-title":"Eur J Pediatr"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181300057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181300057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T13:42:39Z","timestamp":1644414159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929181300057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S014929181300057X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.02.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}